Morgan Stanley Q2 2026: Record Revenue but Valuation Stretched

What happened

Morgan Stanley reported record Q2 2026 revenue exceeding $21 billion, driven by strong client activity across institutional securities, wealth management, and investment management. CEO Ted Pick highlighted the firm's integrated business model as a key driver. However, the DeepValue master report maintains a 'Potential Sell' rating, arguing that 2025 was a cyclical high and current valuation at ~19x earnings and ~2.7x book embeds unsustainable high returns. While the Q2 results are impressive, they are consistent with the report's bull case that already assumed continued strength, but the base case expects normalization to mid-teens ROTCE. Investors should weigh the near-term momentum against the risk of multiple compression as activity normalizes.

Implication

The record Q2 result underscores Morgan Stanley's robust franchise and the strength of the current capital markets cycle. However, the DeepValue report highlights that the stock's premium multiples—~19x trailing EPS and ~2.7x book—already price in sustained high returns. Given that 2025 likely represented a cyclical peak, investors should not extrapolate Q2's performance linearly. The report's base case fair value of $180 suggests limited upside from current levels, with downside to $150 in a normalization scenario. For long-term holders, maintaining discipline is key: consider trimming on strength towards the $205 trim level cited by the report, and look for a better entry near $165. The thesis will be tested if subsequent quarters show ROTCE dipping towards mid-teens, which would lead to multiple contraction.

Thesis delta

The record Q2 2026 revenue supports the bull case scenario of a stronger-for-longer capital markets cycle, delaying the anticipated normalization. However, the DeepValue report's core thesis—that current valuation embeds unsustainable 20%+ ROTCE—remains intact, as the stock price already reflects this outcome. The probability of the bear case may have diminished slightly, but the base case still dominates given the cyclical nature of investment banking and trading revenues. No upgrade to the rating is warranted without evidence that the elevated returns are structurally sustainable beyond the current cycle.